These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 5391905)
1. [Side effects of tetanus toxoid. II. Antigenic materials derived from the constituents of the medium for toxoid preparation]. Akama K; Yamamoto A Nihon Saikingaku Zasshi; 1969 Nov; 24(11):595-601. PubMed ID: 5391905 [No Abstract] [Full Text] [Related]
2. [Side reactions of tetanus toxoid. I. Sensitizing ability of materials included in the medium]. Yamamoto A; Akama K Nihon Saikingaku Zasshi; 1969 Aug; 24(8):359-64. PubMed ID: 5389306 [No Abstract] [Full Text] [Related]
3. A few remarks on the preparation of tetanus toxin and toxoid on casein hydrolysate medium. Lettl A; Nekvasilová K; Moravec K; Stejskal A; Petera A J Hyg Epidemiol Microbiol Immunol; 1968; 12(3):324-34. PubMed ID: 4891178 [No Abstract] [Full Text] [Related]
4. Antigenic and immunogenic studies on purified tetanus toxoid. Nielsen PA; Ablondi FB; Querry MV; Gussoni C; Cooper MS J Immunol; 1967 Jun; 98(6):1248-56. PubMed ID: 4961126 [No Abstract] [Full Text] [Related]
5. Collaborative assay of a proposed international standard for tetanus toxoid (adsorbed). van Ramshorst JD; Sundaresan TK Bull World Health Organ; 1972; 46(1):53-66. PubMed ID: 4537335 [TBL] [Abstract][Full Text] [Related]
6. A simple method for purification of tetanus toxoid. Lahiri B; Dutta SK Indian J Exp Biol; 1984 Oct; 22(10):557-9. PubMed ID: 6530253 [No Abstract] [Full Text] [Related]
7. Current developments in production and testing of tetanus and diphtheria vaccines. Relyveld EH Prog Clin Biol Res; 1980; 47():51-76. PubMed ID: 7010379 [No Abstract] [Full Text] [Related]
8. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed. Sesardic D; Winsnes R; Rigsby P; Tierney R; Gaines-Das R Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430 [TBL] [Abstract][Full Text] [Related]
9. [Technical aspects of the tetanus toxoid preparation at the Leopold Izquieta Pérez National Institute of Hygiene in Guayaquil, Ecuador]. Vanegas Alvarado M Rev Ecuat Hig Med Trop; 1968; 25(2):173-7. PubMed ID: 4889764 [No Abstract] [Full Text] [Related]
10. Replacement of the international standard for tetanus antitoxin and the use of the standard in the flocculation test. Spaun J; Lyng J Bull World Health Organ; 1970; 42(4):523-34. PubMed ID: 5310949 [TBL] [Abstract][Full Text] [Related]
11. International collaborative studies on potency assays of diphtheria and tetanus toxoids. Van Ramshorst JD; Sundaresan TK; Outschoorn AS Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488 [TBL] [Abstract][Full Text] [Related]
12. The immunopurification of tetanus toxoid. Hughes M; Thomson RO; Knight P; Stephen J J Appl Bacteriol; 1974 Dec; 37(4):603-21. PubMed ID: 4215786 [No Abstract] [Full Text] [Related]
13. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use. Beuvery EC; Speijers GJ; Lutz BI; Freudenthal D; Kanhai V; Haagmans B; Derks HJ Dev Biol Stand; 1986; 63():117-28. PubMed ID: 3091432 [TBL] [Abstract][Full Text] [Related]
14. Alternative approach and evaluation of three potency assay methods for testing adsorbed tetanus toxoid. Maheshwari SC; Sharma SB; Kumar A; Sokhey J J Commun Dis; 1998 Mar; 30(1):12-8. PubMed ID: 9842159 [TBL] [Abstract][Full Text] [Related]
15. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449 [TBL] [Abstract][Full Text] [Related]
16. [Experimental studies of the reactivity of adsorbed tetanus toxoids in guinea pigs]. Künzel W; Meissner C Arch Exp Veterinarmed; 1985 May; 39(3):450-5. PubMed ID: 4051659 [No Abstract] [Full Text] [Related]
18. Studies on adjuvants for human prophylactics. II. Influence of the route of injection on the activity of adjuvants to tetanus toxoid in guinea pigs. Yamamoto A; Murata R Jpn J Med Sci Biol; 1978; 31(5-6):393-406. PubMed ID: 156804 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of tetanus. Experimental trial in guinea pigs with serum, toxoid and serotoxoid]. Corrêa A; Tavares J Rev Inst Med Trop Sao Paulo; 1972; 14(4):246-8. PubMed ID: 5084219 [No Abstract] [Full Text] [Related]
20. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein. Beuvery EC; Roy R; Kanhai V; Jennings HJ Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]